187 related articles for article (PubMed ID: 36582611)
1. Spatiotemporal scaling changes in gait in a progressive model of Parkinson's disease.
Doyle AM; Bauer D; Hendrix C; Yu Y; Nebeck SD; Fergus S; Krieg J; Wilmerding LK; Blumenfeld M; Lecy E; Spencer C; Luo Z; Sullivan D; Brackman K; Ross D; Best S; Verma A; Havel T; Wang J; Johnson L; Vitek JL; Johnson MD
Front Neurol; 2022; 13():1041934. PubMed ID: 36582611
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease.
Wang XH; Lu G; Hu X; Tsang KS; Kwong WH; Wu FX; Meng HW; Jiang S; Liu SW; Ng HK; Poon WS
BMC Neurosci; 2012 Nov; 13():142. PubMed ID: 23151254
[TBL] [Abstract][Full Text] [Related]
3. Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).
Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
Neuroscience; 1997 Dec; 81(3):745-55. PubMed ID: 9316026
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease.
Rochester L; Yarnall AJ; Baker MR; David RV; Lord S; Galna B; Burn DJ
Brain; 2012 Sep; 135(Pt 9):2779-88. PubMed ID: 22961550
[TBL] [Abstract][Full Text] [Related]
5. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
Molinet-Dronda F; Blesa J; Del Rey NL; Juri C; Collantes M; Pineda-Pardo JA; Trigo-Damas I; Iglesias E; Hernández LF; Rodríguez-Rojas R; Gago B; Ecay M; Prieto E; García-Cabezas MÁ; Cavada C; Rodríguez-Oroz MC; Peñuelas I; Obeso JA
Neurobiol Dis; 2022 Jun; 167():105669. PubMed ID: 35219857
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of gait hypokinesia in Parkinson's disease.
Morris ME; Iansek R; Matyas TA; Summers JJ
Brain; 1994 Oct; 117 ( Pt 5)():1169-81. PubMed ID: 7953597
[TBL] [Abstract][Full Text] [Related]
7. Atractylon, a novel dopamine 2 receptor agonist, ameliorates Parkinsonian like motor dysfunctions in MPTP-induced mice.
Li H; Wang F; Zhou Z; Jiang X; Li F; Feng Y; Liu C; Zhang Y; Fan S; Wu X; Huang C
Neurotoxicology; 2022 Mar; 89():121-126. PubMed ID: 35104500
[TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.
Rosa AI; Duarte-Silva S; Silva-Fernandes A; Nunes MJ; Carvalho AN; Rodrigues E; Gama MJ; Rodrigues CMP; Maciel P; Castro-Caldas M
Mol Neurobiol; 2018 Dec; 55(12):9139-9155. PubMed ID: 29651747
[TBL] [Abstract][Full Text] [Related]
9. Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed.
Turcato AM; Godi M; Giardini M; Arcolin I; Nardone A; Giordano A; Schieppati M
PLoS One; 2018; 13(5):e0197264. PubMed ID: 29750815
[TBL] [Abstract][Full Text] [Related]
10. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
[TBL] [Abstract][Full Text] [Related]
11. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.
Faist M; Xie J; Kurz D; Berger W; Maurer C; Pollak P; Lücking CH
Brain; 2001 Aug; 124(Pt 8):1590-600. PubMed ID: 11459750
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gait in progressive supranuclear palsy, Parkinson's disease and healthy older adults.
Egerton T; Williams DR; Iansek R
BMC Neurol; 2012 Oct; 12():116. PubMed ID: 23031506
[TBL] [Abstract][Full Text] [Related]
13. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
Ferreira F; Gago MF; Bicho E; Carvalho C; Mollaei N; Rodrigues L; Sousa N; Rodrigues PP; Ferreira C; Gama J
J Biomech; 2019 Jul; 92():98-104. PubMed ID: 31182234
[TBL] [Abstract][Full Text] [Related]
14. Effect of step-synchronized vibration stimulation of soles on gait in Parkinson's disease: a pilot study.
Novak P; Novak V
J Neuroeng Rehabil; 2006 May; 3():9. PubMed ID: 16674823
[TBL] [Abstract][Full Text] [Related]
15. A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification.
Seo J; Lee Y; Kim BS; Park J; Yang S; Yoon HJ; Yoo J; Park HS; Hong JJ; Koo BS; Baek SH; Jeon CY; Huh JW; Kim YH; Park SJ; Won J; Ahn YJ; Kim K; Jeong KJ; Kang P; Lee DS; Lim SM; Jin YB; Lee SR
J Neurosci Methods; 2019 Jan; 311():277-287. PubMed ID: 30391524
[TBL] [Abstract][Full Text] [Related]
16. A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.
Geldenhuys WJ; Guseman TL; Pienaar IS; Dluzen DE; Young JW
PeerJ; 2015; 3():e1175. PubMed ID: 26339553
[TBL] [Abstract][Full Text] [Related]
17. Gait performance and non-motor symptoms burden during dual-task condition in Parkinson's disease.
Zhang M; Gan Y; Wang X; Wang Z; Feng T; Zhang Y
Neurol Sci; 2023 Jan; 44(1):181-190. PubMed ID: 36125574
[TBL] [Abstract][Full Text] [Related]
18. Agreement between the GAITRite
Vítečková S; Horáková H; Poláková K; Krupička R; Růžička E; Brožová H
PeerJ; 2020; 8():e8835. PubMed ID: 32509441
[TBL] [Abstract][Full Text] [Related]
19. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
Amende I; Kale A; McCue S; Glazier S; Morgan JP; Hampton TG
J Neuroeng Rehabil; 2005 Jul; 2():20. PubMed ID: 16042805
[TBL] [Abstract][Full Text] [Related]
20. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
